A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer

Authors :: Joel M. Reid
Scott H. Kaufmann
Jake Allred
J. Lea
V. Kennedy
A.E. Wahner Hendrickson
Daniel Satele
B. Corr
Elizabeth M. Swisher
Araba A. Adjei
Brian A. Costello
Gini F. Fleming
Sarah Taylor
Charles Erlichman
S. P. Ivy
Janet Lensing
A. Jewell
Source :: Annals of Oncology. 29:viii357
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
Veliparib
business.industry
Hematology
medicine.disease
Clinical trial
chemistry.chemical_compound
chemistry
Internal medicine
medicine
Topotecan
In patient
Ovarian cancer
business
medicine.drug
Platinum resistant

Full Text Access

Tools